Immunomic Therapuetics Inc entered the industry of Vaccines in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 325414, which describes it as a Vaccines. For further clarification, the SIC classifies this business under the code 2836 and described it as a Vaccines. The business provides service to the B2B market.
To acquire more information, please contact William Hearl by calling (717) 327-1919 during business hours. You can also write to the business’ Headquarters at 1214 Res Boulevard # 201, Hummelstown, Pennsylvania PA 17036. You can also visit the company’s website at immunomix.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Immunomic Therapuetics Inc |
| Representative: | William Hearl |
| Place of Business: | 1214 Res Boulevard # 201, Hummelstown, PA 17036 |
| Contact Number: | (717) 327-1919 |
| Website: | immunomix.com |
| Type of Service: | Vaccines |
| SIC Number: | 2836 |
| NAICS Number: | 325414 |
| Locality: | Headquarters |
| Market Type: | B2B (Business to Business) |
| Began: | 2005 |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Immunomic Therapuetics Inc is a company operating from Dauphin, Pennsylvania providing professional Vaccines and relevant B2B variables. It was founded in 2005 and registered with the SIC code 2836 as Vaccines, and with the NAICS code 325414 as Vaccines.
With a current employee count of 1 to 4, Immunomic Therapuetics Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative William Hearl at (717) 327-1919 for related queries, or to locate its Headquarters using the coordinates 40.262648,-76.686498.
The Headquarters can also be found at the street address 1214 Res Boulevard # 201 in Hummelstown, Pennsylvania 17036 and can be engaged online through the company website at immunomix.com, the company Twitter , and Facebook page .